Susan Yue

587 total citations
13 papers, 400 citations indexed

About

Susan Yue is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, Susan Yue has authored 13 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Nephrology. Recurrent topics in Susan Yue's work include Bone health and treatments (5 papers), Bone Metabolism and Diseases (4 papers) and Parathyroid Disorders and Treatments (3 papers). Susan Yue is often cited by papers focused on Bone health and treatments (5 papers), Bone Metabolism and Diseases (4 papers) and Parathyroid Disorders and Treatments (3 papers). Susan Yue collaborates with scholars based in United States, Canada and France. Susan Yue's co-authors include Hongjie Deng, David L. Kendler, Myles Wolf, Matthew R. Weir, Roslyn B. Mannon, Nelson Kopyt, Flavio Vincenti, Jon Von Visger, Jacques P. Brown and Chao Yan and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and American Journal of Kidney Diseases.

In The Last Decade

Susan Yue

12 papers receiving 392 citations

Peers

Countries citing papers authored by Susan Yue

Since Specialization

Citations

This map shows the geographic impact of Susan Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Yue more than expected).

Fields of papers citing papers by Susan Yue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Yue. The network helps show where Susan Yue may publish in the future.

Co-authorship network of co-authors of Susan Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Yue. A scholar is included among the top collaborators of Susan Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Yue. Susan Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Demographic and clinical characteristics of initial patients receiving amyloid‐targeting treatments in the United States after regulatory approval 2025 ·Alzheimer s & Dementia ·Soeren Mattke, Susan Yue, A. C. Becker, Ying Liu	0
2	Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study 2020 ·Biology of Blood and Marrow Transplantation ·Susan E. Prockop, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu‐Arja, Kris M. Mahadeo, Wen‐Kai Weng, Koen van Besien, David M. Loeb, Sunita D. Nasta, Eneida R. Nemecek, Minoti Hiremath, Susan Yue, Yan Sun, Willis H. Navarro, Sarah Nikiforow	2
3	Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab 2019 ·Osteoporosis International ·David L. Kendler, Henry G. Bone, Francesco Massari, Evelien Gielen, Santiago Palacios, Judy Maddox, Chao Yan, Susan Yue, Rajani Dinavahi, Cesar Libanati, Andreas Grauer	75
4	Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplants (HCT) Treated with Tabelecleucel on an Expanded Access Program 2019 ·Blood ·Susan E. Prockop, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu‐Arja, Kris M. Mahadeo, Wen‐Kai Weng, Koen van Besien, David M. Loeb, Sunita D. Nasta, Eneida R. Nemecek, Minoti Hiremath, Susan Yue, Yan Sun, Willis H. Navarro, Sarah Nikiforow	5
5	Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis 2018 ·The Journal of Clinical Endocrinology & Metabolism ·David W. Dempster, Jacques P. Brown, Astrid Fahrleitner‐Pammer, David L. Kendler, (unknown), Ivo Valter, Rachel B. Wagman, Xiang Yin, Susan Yue, Georges Boivin	58
6	Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study 2018 ·Archives of Osteoporosis ·Stuart L. Silverman, Ethel S. Siris, (unknown), Chris Recknor, Αλεξάνδρα Παπαϊωάννου, Jacques P. Brown, Deborah T. Gold, E. Michael Lewiecki, (unknown), Akhila Balasubramanian, Susan Yue, Bradley S. Stolshek, David L. Kendler	22
7	Effects of Denosumab (Dmab) on bone matrix mineralization: results from the phase 3 FREEDOM trial 2016 ·Bone Abstracts ·David W. Dempster, Jacques P. Brown, Susan Yue, Delphine Farlay, (unknown), Jenny Z. Song, Andrea Wang, Rachel B. Wagman, Georges Boivin	1
8	A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation 2015 ·Transplantation ·Myles Wolf, Matthew R. Weir, Nelson Kopyt, Roslyn B. Mannon, Jon Von Visger, Hongjie Deng, Susan Yue, Flavio Vincenti	102
9	Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design 2015 ·BMC Nephrology ·B. Diane Reams, Paul J. Dluzniewski, Thy P., Susan Yue, Brian D. Bradbury, Abhijit V. Kshirsagar, M. Alan Brookhart	14
10	A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism 2014 ·American Journal of Transplantation ·P. Evenepoel, Kerry Cooper, Hallvard Holdaas, Piergiorgio Messa, G. Mourad, Klaus Ølgaard, Piotr Rutkowski, Heidi Schaefer, Hongjie Deng, José‐Vicente Torregrosa, Rudolf P. Wüthrich, Susan Yue	68
11	Early Trends From the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS) 2013 ·American Journal of Kidney Diseases ·Steven M. Brunelli, Keri L. Monda, John M. Burkart, Matthew Gitlin, Peter J. Neumann, Grace S. Park, (unknown), Susan Yue, Brian D. Bradbury, Robert J. Rubin	34
12	Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents 2013 ·Clinical Pharmacokinetics ·Sameer Doshi, Wojciech Krzyżański, Susan Yue, Steven Elliott, Andrew Chow, Juan José Pérez Ruixo	17
13	Risk of Pure Red Cell Aplasia in Patients With Hepatitis C Receiving Antiviral Therapy and an Erythropoiesis-Stimulating Agent 2013 ·Clinical Gastroenterology and Hepatology ·Jérôme Rossert, Susan Yue, Karen Smirnakis, Daniel T. Mytych, Larry E. Johnson, Elias Kouchakji, Nicole Casadevall	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact